Abstract
The aim of this study was to investigate the prevalence, predictors and radiological findings of primary Sjögren’s syndrome (pSS)-associated lung involvement. This retrospective cohort study included 123 patients with demographic, clinical, laboratory and radiological data who were diagnosed with pSS. Lung involvement was defined based on the presence of pulmonary signs/symptoms and/or impaired pulmonary function tests along with alterations in high-resolution computerized tomography (HRCT). Thirty patients (24.4%) had pulmonary signs/symptoms at the initial presentation and/or during the follow-up period. Based on the criteria, 14 patients (11.4%) were defined as having pSS with lung involvement. The smoking rate, male/female ratio and the mean ages were found to be higher in patients with lung involvement (P < 0.05). Positive IgM-rheumatoid factor (RF), anti-La and anti-Ro results, the presence of hypergammaglobulinemia and lymphopenia had high specificity despite the low sensitivity rates to detect pSS-associated lung disease. A significant difference was found in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) results between the patients with and without lung involvement. Impaired FEV1 had high specificity and positive predictive value compared to impaired FVC, particularly in non-smoker patients. The most frequent HRCT finding was ground-glass attenuation (64.3%). Other common findings were bronchiectasis, reticular pattern and honeycombing. The lesions involved predominantly the lower lobes. In conclusion, the presence of hypergammaglobulinemia and lymphopenia, positivity for RF, anti-La and anti-Ro, and impaired (FVC) and/or FEV1 values could be the predictive parameters with a high specificity despite the low sensitivity rates. Smoking history, male gender and age are also risk factors. These parameters may be helpful to distinguish pSS-associated lung involvement from lung disorders unrelated to pSS.
Similar content being viewed by others
References
Fox RI (2005) Sjogren’s syndrome. Lancet 366:321–331
Gardiner P, Ward C, Allison A et al (1993) Pleuropulmonary abnormalities in primary Sjogren’s syndrome. J Rheumatol 20:831–837
Deheinzelin D, Capelozzi VL, Kairalla RA et al (1996) Interstitial lung disease in primary Sjogren’s syndrome. Clinical–pathological evaluation and response to treatment. Am J Respir Crit Care Med 154:794–799
Davidson BK, Kelly CA, Griffiths ID (2000) Ten-year follow-up of pulmonary function in patients with primary Sjogren’s syndrome. Ann Rheum Dis 59:709–712
Cain HC, Noble PW, Matthay RA (1998) Pulmonary manifestations of Sjogren’s syndrome. Clin Chest Med 19:687–699
Ito I, Nagai S, Kitaichi M et al (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171:632–638
Yamadori I, Fujita J, Bandoh S et al (2002) Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren’s syndrome. Rheumatol Int 22:89–92
Travis WD, Colby TV, Koss MN (2002) Non-neoplastic disorders of the lower respiratory tract. Armed Forces Institute of Pathology, Washington, DC
Yazisiz V, Avci AB, Erbasan F et al (2009) Diagnostic performance of minor salivary gland biopsy, serological and clinical data in Sjogren’s syndrome: a retrospective analysis. Rheumatol Int 29:403–409
Theander E, Manthorpe R, Jacobsson LT (2004) Mortality and causes of death in primary Sjogren’s syndrome: a prospective cohort study. Arthritis Rheum 50:1262–1269
Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304
Taouli B, Brauner MW, Mourey I et al (2002) Thin-section chest CT findings of primary Sjogren’s syndrome: correlation with pulmonary function. Eur Radiol 12:1504–1511
Ramos-Casals M, Solans R, Rosas J et al (2008) Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87:210–219
Saag KG, Kolluri S, Koehnke RK et al (1996) Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 39:1711–1719
Shadick NA, Fanta CH, Weinblatt ME et al (1994) Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 73:161–170
Anaya JM, Diethelm L, Ortiz LA et al (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24:242–254
Mori S, Cho I, Koga Y et al (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513–1521
Garcia-Carrasco M, Siso A, Ramos-Casals M et al (2002) Raynaud’s phenomenon in primary Sjogren’s syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol 29:726–730
Alexander EL, Arnett FC, Provost TT et al (1983) Sjogren’s syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 98:155–159
Moutsopoulos HM, Zerva LV (1990) Anti-Ro (SSA)/La (SSB) antibodies and Sjogren’s syndrome. Clin Rheumatol 9:123–130
Franquet T, Gimenez A, Monill JM et al (1997) Primary Sjogren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 169:655–658
Tanaka N, Kim JS, Newell JD et al (2004) Rheumatoid arthritis-related lung diseases: CT findings. Radiology 232:81–91
Galie N, Manes A, Farahani KV et al (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14:713–717
Launay D, Hachulla E, Hatron PY et al (2007) Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86:299–315
Bertoni M, Niccoli L, Porciello G et al (2005) Pulmonary hypertension in primary Sjogren’s syndrome: report of a case and review of the literature. Clin Rheumatol 24:431–434
Vassiliou VA, Moyssakis I, Boki KA et al (2008) Is the heart affected in primary Sjogren’s syndrome? An echocardiographic study. Clin Exp Rheumatol 26:109–112
Turesson C, Jacobsson L, Bergstrom U (1999) Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 38:668–674
Acknowledgments
This study was supported by the Akdeniz University, Scientific Research Projects Unit.
Conflict of interest statement
The authors have declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yazisiz, V., Arslan, G., Ozbudak, İ.H. et al. Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors?. Rheumatol Int 30, 1317–1324 (2010). https://doi.org/10.1007/s00296-009-1152-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1152-8